Phase Diagnostics is developing handheld, one-step, rapid point-of-care devices for the detection of various biomarkers. The firm's proprietary technology combines the ease-of-use and very low cost of rapid point-of-care diagnostics with the very high accuracy of lab-based tests, The objective of Phase Diagnostics is to offer a range of rapid diagnostic testing kits that can detect various analytes of interest (i.e. viruses, bacteria, proteins, etc.). To that end, Phase Diagnostics devices leverage the companys 3PS (3-Dimensional Paper Sensors) technology, a patented detection system that combines the following two steps: Concentration: Concentrate analyte(s) of interest 10-1000x by means of Aqueous Two-Phase Systems (ATPS) Detection: Observe presence (or absence) of analyte(s) using a Lateral Flow Immunoassay (LFA) testing strip. By performing these two steps in sequence, the Phase Diagnostic's system effectively lowers the detection threshold of existing LFA tests by 10-1000 fold with the added advantage of fast turnaround time..
